The UF CTSI brings together researchers from the University of Florida and Florida State University to share research outcomes and collaborate on opportunities to advance clinical and translational science.
Schedule & Registration
COVID 19 Clinical and Translational Science Updates: Lightning Sessions – 5-minute presentations (Zoom)
|Monday, Feb. 7, 10 a.m. – Noon||Clinical Care; Therapeutics & Vaccines||Register to attend||View presentations|
|Wednesday, Feb. 9, 10 a.m. – Noon||Detection, Surveillance & Risk Factors||Register to attend||View presentations|
|Wednesday, Feb. 9, 2 – 4 p.m.||Dissemination, Policy, Public Information, PPE & Health Care Delivery||Register to attend||View presentations|
|Thursday, Feb. 10, 3 – 5 p.m.||Mental Health; Using Data||Register to attend||View presentations|
|Friday, Feb. 11, 1 – 3 p.m.||Social Determinants of Health; Health Equity; Medical Engineering||Register to attend||View presentations|
If you are interested in presenting your own research during these sessions, please let us know by completing this form. We will limit lightning session presentations per session to 12.
COVID 19 Clinical and Translational Science Updates: Lightning Sessions – 5-minute presentations (Zoom). Additional presenters and presentations may be added – check back for updates!
Clinical Care, Therapeutics & Vaccines – Feb. 7, 10 a.m. – noon
|Moldawer, Efron, Loftus||Immunological Description of COVID19 Sepsis vs Bacterial Sepsis|
|Nicole Iovine, MD||A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults|
|Matthew Schaller, PhD||Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses|
|Elizabeth Shenkman, MD||ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications|
|Leah Reznikov, PhD||Targeted disruption of ACE2-SARS-CoV-2 interactions using small molecules|
Detection, Surveillance & Risk Factors – Feb. 9, 10 a.m. – noon
|Josephine Esquivel-Upshaw, DMD||A handheld electrical sensor for rapid, sensitive detection and quantification of SARS-CoV-2 from saliva|
|Kartik Cherabuddi, PhD||COVID-19 vaccine and infection in young adults and university system|
|Christopher Vulpe, MD, PhD||Identification of host determinants of SARS-CoV-2 infection|
|Jane Benoit, PhD||Human coronavirus proteins alter chromatin dynamics|
Dissemination, Policy, Public Information, PPE & Health Care Delivery – Feb. 9, 2-4 p.m.
|Eric Cooks, PhD||This research will explore provider perspectives for strengthening research partnerships to implement cancer screening interventions during the COVID-19 pandemic.|
|Steven Munger, PhD||Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance|
|Elizabeth Shenkman, MD||Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19|
|Carma Bylund, PhD||Doctor-Patient Cancer Communications through Telemedicine during COVID-19|
Mental Health and Using Data – Feb. 10, 3-5 p.m.
|Nicola Sambuco, PhD||Exposure to COVID-19 trauma and risk factors for developing psychopathology|
|Elizabeth Shenkman, MD||Primary Data Collection, Active Surveillance Study of Post-Vaccination Events of Interest Among Patients Vaccinated with Pfizer/BioNTech COVID-19 Vaccine or HERO-TOGETHER Registry|
|Tanja Magoc, PhD||Rapid Creation of a De-Identified COVID-19 Dataset for Clinical Research|
|Laura Marks, PHD||Psychological and Substance Use Impacts of COVID-19 Perceived Threat in Racially Diverse Emerging Adults|
Social Determinants of Health, Medical Engineering – Feb. 11, 1-3 p.m.
|Lauri Baker, PhD||Lessons from COVID-19: Positioning Regional Food Supply Chains for Future Pandemics, Natural Disasters and Human-made Crises|
|Michelle Danyluk, PhD||A collaborative approach to managing SARS-CoV-2 within the food industry; filling data gaps and impacting behaviors|
|Elizabeth Shenkman, MD||Community-Engagement Research Alliance Against COVID-19 in Disproportionately Affected Communities (CEAL)|
|Melissa Radey, PhD||Social Support and Well-being Among Low-income Mothers During the COVID-19 Pandemic|
|Zhonghui Fan,PhD||Multiplexed Airborne Virus Collection and Detection at the Point-of-Care|
Community Engagement and COVID-19
Postponed – Date TBD
During this session, leaders from across UF and FSU will share highlights of their work, research and programs.
Conducting COVID-19 Research
Monday, March 28, 9 a.m. – Noon
Research services and core facilities across campus created new workflows, new opportunities and continue to advance research capabilities at UF and FSU. Hear from those who help you conduct your research.
The UF CTSI COVID-19 pilot awardees and other investigators researching the many arms of COVID-19 are also invited to present their research at this poster session and reception. All are welcome to attend. This will be an in-person event but location is TBD.
The CTSI and the Office of the Senior Vice President for Health Affairs created a $2 million pilot research fund for scientists with translational projects that can be rapidly mobilized.